|
AP13770a-ev
|
Abcepta, Inc.
|
CELA3B [N-term] [RB33872], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP13770a
|
Abcepta, Inc.
|
CELA3B [N-term] [RB33872], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP7145b-ev
|
Abcepta, Inc.
|
MARK4 [C-term] [RB5447], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP7145b
|
Abcepta, Inc.
|
MARK4 [C-term] [RB5447], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP7726b-ev
|
Abcepta, Inc.
|
TRIB1 [C-term] [RB9762], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP7726b
|
Abcepta, Inc.
|
TRIB1 [C-term] [RB9762], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
CT372
|
U-CyTech Biosciences
|
U-CyTech anti-CD3/CD28 stimulus for human PBMC
|
Human
|
ELISPOT
|
|
|
ATGA0504-100ul
|
NKMax Bio (ATGen)
|
DYKDDDDK Epitope Tag [AT3G6], Mouse Monoclonal Antibody
|
|
ELISA, WB
|
|
|
ATGA0504-50ul
|
NKMax Bio (ATGen)
|
DYKDDDDK Epitope Tag [AT3G6], Mouse Monoclonal Antibody
|
|
ELISA, WB
|
|
|
HY-108507-1mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
|
HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-100mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-25mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-5mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-50mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
